A Discussion of Arterial Blood Gas Analysis and Interpretation
Arterial blood gases (ABGs) provide valuable information to help inform patient care decisions and for monitoring whether treatment is bringing about desired outcomes.
Arterial blood gases (ABGs) provide valuable information to help inform patient care decisions and for monitoring whether treatment is bringing about desired outcomes.
Arterial blood gases (ABGs) provide valuable information to help inform patient care decisions and for monitoring whether treatment is bringing about desired outcomes.
Read MoreA look at the latest diagnostic and testing products from Ambu, Rheonix, BioFire, Hologic, and Abbott.
Read MoreThe US FDA issued a public alert that the Abbott ID Now point-of-care test may return false negative results for COVID-19 patients.
Read MoreAbbott has received an EUA from the FDA for its Abbott ID Now COVID-19 test, which delivers positive results in as little as 5 min and negative results in 13 min.
Read MoreAbbott has received an FDA emergency use authorization (EUA) for its Abbott RealTime SARS-CoV-2 molecular test to detect COVID-19.
Read MoreThe US FDA has cleared Abbott’s next-generation Influenza A & B 2 and Strep A 2 molecular assays for point-of-care testing.
Read MoreThe Alere i Influenza A & B 2 test has received 510(k) marketing clearance from the US FDA for the detection of influenza A and B infection in children and adults, according to Alere Inc.
Read MoreThe latest blood gas analyzers on the market from Alere, Nova Biomedical, and Instrumentation Labs.
Read MoreThe Alere i RSV test will now be available in physicians’ offices, hospital emergency rooms, and walk-in clinics throughout the US.
Read MoreThree blood gas analysis devices are highlighted from manufacturers Alere, Instrumentation Laboratory, and Radiometer America.
Read MoreThe latest advancements in blood gas analysis technology are focused on fast, reliable, point-of-care solutions that improve diagnosis times for patients and clinicians.
Read MoreBlood gas analysis technology continues to shorten the length of time between testing and results, thanks to improved technology and a focus on point-of-care devices.
Read More